You are here: Home » News-ANI » Health
Business Standard

India adopts new strategy to accelerate lymphatic filariasis elimination


Union Minister J.P. Nadda on Wednesday inaugurated the 10th meeting of the Global Alliance to Eliminate Lymphatic Filariasis (GAELF).

The minister launched India's Accelerated Plan for Lymphatic Filariasis Elimination (APELF) on the occasion.

Acknowledging that India's LF elimination programme needs a push, Nadda said that strategies like the Triple Drug Therapy or IDA [Ivermectin, diethylcarbamazine (DEC) and Albendazole], community engagement for successful MDA implementation and use of DEC-medicated salt, which are all part of the APELF, will be deployed to strengthen the country's LF elimination efforts.

The 10th GAELF meeting brings together various country programmes, three pharmaceutical companies (GSK, Eisai and MSD) that have donated drugs, non-governmental organizations, research organisations, donor governmental agencies, and the World Organisation (WHO).

The GAELF theme this year is 'Celebrating progress towards elimination: Voices from the field on overcoming programme challenges'. Programme managers and senior ministerial personnel from all LF endemic countries will discuss experiences, challenges and current needs at the meeting.

Eleven countries - Cambodia, Cook Islands, Egypt, Maldives, Marshall Islands, Niue, Sri Lanka, Thailand, Togo, Tonga, Vanuatu - were awarded at the meeting today for eliminating LF as a public concern.

Minister of State for Health and Family Welfare, India, Ashwini Kumar Choubey reiterated the need to address one of the major challenges - compliance to treatment. He said it is crucial to encourage the community to consume preventive medicines given out during MDA.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, June 13 2018. 15:05 IST